Mushroom magic draws $80M injection for London-based mental health startup

Natalie Grover

Reporter

The coronavirus outbreak has interfered with a mid-stage depression trial testing its psilocybin compound, but the magic of the mushroom has scored Peter Thiel-backed Compass …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Mushroom magic draws $80M injection for London-based mental health startup

Natalie Grover

Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Trump blog: Judge extends nationwide block on NIH payment cuts

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

Former FDA chief calls job cuts ‘haphazard, poorly thought-out’

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Mush­room mag­ic draws $80M in­jec­tion for Lon­don-based men­tal health start­up

Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Mushroom magic draws $80M injection for London-based mental health startup